dx 9065a has been researched along with risedronic acid in 1 studies
| Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (risedronic acid) | Trials (risedronic acid) | Recent Studies (post-2010) (risedronic acid) |
|---|---|---|---|---|---|
| 92 | 7 | 8 | 1,318 | 290 | 487 |
| Protein | Taxonomy | dx 9065a (IC50) | risedronic acid (IC50) |
|---|---|---|---|
| Farnesyl pyrophosphate synthase | Homo sapiens (human) | 0.1104 | |
| Farnesyl pyrophosphate synthase | Leishmania donovani | 0.1699 | |
| Farnesyl diphosphate synthase | Toxoplasma gondii | 0.074 | |
| Farnesyl diphosphate synthase | Trypanosoma cruzi | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamaguchi, R; Kataoka, M; Kokubo, H; Kozaki, T; Masaoka, Y; Sakuma, S; Tanno, FK; Yamashita, S | 1 |
1 other study(ies) available for dx 9065a and risedronic acid
| Article | Year |
|---|---|
Effect of administration site in the gastrointestinal tract on bioavailability of poorly absorbed drugs taken after a meal.
Topics: Animals; Biological Availability; Etidronic Acid; Food-Drug Interactions; Gastrointestinal Transit; Infusions, Intravenous; Intestinal Absorption; Intestinal Mucosa; Male; Molecular Structure; Naphthalenes; Propionates; Rats; Rats, Wistar; Risedronic Acid; Trientine | 2007 |